GDF15 attenuates sepsis-induced acute lung injury by suppressing the HIF-1α/LDHA pathway
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.115198 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Xiandong Kuang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Institute of Translational Medicine, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Sepsis, Acute Lung Injury, Hypoxia-Inducible Factor 1, alpha Subunit, Growth Differentiation Factor 15. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
BACKGROUND: Sepsis-associated acute lung injury (ALI) is characterized by endothelial inflammation and metabolic reprogramming. Growth Differentiation Factor 15 (GDF15), a stress-inducible cytokine, may regulate immunometabolic crosstalk, but its endothelial-specific role remains undefined. METHODS: Using LPS-induced septic mice and human endothelial cells, GDF15 expression was dysregulated via AAV-mediated overexpression or siRNA knockdown. Pharmacological modulators included: HIF-1α inhibitor BAY 87-2243, HIF-1α activator 1,4-DPCA, LDHA inhibitor FX-11, and sodium lactate. Endothelial inflammation was evaluated through adhesion molecules (ICAM-1, VCAM-1, VEGF-A) and cytokines (TNF-α, IL-6) at protein levels. RESULTS: GDF15 was upregulated in pulmonary endothelia of septic mice and contributed to endothelial dysfunction, evidenced by elevated adhesion molecules (ICAM-1/VCAM-1/VEGF-A), cytokines (TNF-α/IL-6), and impaired barrier repair. GDF15 overexpression alleviated lung injury and inflammation, while its knockdown aggravated pathology. Mechanistic studies revealed that GDF15 inhibits the HIF-1α/LDHA glycolytic axis activated by LPS, reducing cytokine storm and leukocyte adhesion. Critically, HIF-1α inhibitor (BAY 87-2243) and LDHA inhibitor (FX-11) phenocopied GDF15 protection, whereas HIF-1α activator (1,4-DPCA) and sodium lactate negated it, establishing HIF-1α/LDHA as the primary effector pathway. CONCLUSION: GDF15 emerges as a critical endothelial protector in sepsis by suppressing HIF-1α/LDHA-mediated immunometabolic dysregulation. Its synergistic interplay with glycolytic inhibitors highlights a novel therapeutic strategy to target both inflammatory and metabolic drivers of ALI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Institute of Translational Medicine, Renmin Hospital of Wuhan University, Wuhan, China.
- Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
- Department of Clinical Laboratory, Institute of Translational Medicine, Renmin Hospital of Wuhan University, Wuhan, China. Electronic address: iamshuo@whu.edu.cn.
- Department of Clinical Laboratory, Institute of Translational Medicine, Renmin Hospital of Wuhan University, Wuhan, China. Electronic address: rm001316@whu.edu.cn.
Zitieren
APA
Kuang, X., Niu, Z., Huang, Z., Cai, X., Wang, L., Zhang, Y., Luo, J., Zhao, X., Shuo, L., & Zhang, P. (2025). GDF15 attenuates sepsis-induced acute lung injury by suppressing the HIF-1α/LDHA pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115198
Vancouver
Kuang X, Niu Z, Huang Z, Cai X, Wang L, Zhang Y, et al. GDF15 attenuates sepsis-induced acute lung injury by suppressing the HIF-1α/LDHA pathway. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115198
BibTeX
@article{Kuang2025,
author = {Kuang, Xiandong and Niu, Zhili and Huang, Zhaoyang and Cai, Xin and Wang, Li and Zhang, Ye and Luo, Jialong and Zhao, Xincan and Shuo, Li and Zhang, Pingan},
title = {GDF15 attenuates sepsis-induced acute lung injury by suppressing the HIF-1α/LDHA pathway},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.115198}
}
EUVIMED